Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jun:112:126-127.
doi: 10.1016/j.ejim.2023.02.009. Epub 2023 Feb 16.

Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)

Mohammed I Danjuma  1 , Ridhima Kaul  2 , Tamader Alyaarabi  3 , Basant Elsayed  3 , Mohamed Elshafei  4
Affiliations
Comment

Colchicine and mortality outcomes in patients with coronavirus disease (COVID-19)

Mohammed I Danjuma et al. Eur J Intern Med. 2023 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest None of the authors have any relevant conflict of interest to declare.

Comment on

  • Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial.
    Perricone C, Scarsi M, Brucato A, Pisano P, Pigatto E, Becattini C, Cingolani A, Tiso F, Prota R, Tomasoni LR, Cutolo M, Tardella M, Rozza D, Zerbino C, Andreoni M, Poletti V, Bartoloni E, Gerli R; COLVID-19 study group, under the auspices of the Italian Society of Rheumatology (SIR), the Italian Society of Infectious and Tropical Diseases (SIMIT) and the Italian Thoracic Society (ITS-AIPO). Perricone C, et al. Eur J Intern Med. 2023 Jan;107:30-36. doi: 10.1016/j.ejim.2022.10.016. Epub 2022 Oct 31. Eur J Intern Med. 2023. PMID: 36396522 Free PMC article. Clinical Trial.

References

    1. Perricone C., Scarsi M., Brucato A., Pisano P., Pigatto E., et al. Treatment with colchicine in hospitalized patients affected by COVID-19: the COLVID-19 trial. Eur J Intern Med. 2023 Jan 1;107:30–36. - PMC - PubMed
    1. Chiu L., Lo C.H., Shen M., Chiu N., Aggarwal R., et al. Colchicine use in patients with COVID-19: a systematic review and meta-analysis. PLoS ONE. 2021 Dec 28;16(12) - PMC - PubMed
    1. Elshafei M.N., El-Bardissy A., Khalil A., Danjuma M., Mubasher M., et al. colchicine use might be associated with lower mortality in COVID-19 patients: a meta-analysis. Eur J Clin Invest. 2021;51(9):e13645. Sep. - PMC - PubMed
    1. Sanghavi D., Bansal P., Kaur I.P., Mughal M.S., Keshavamurthy C., Cusick A., Schram J., Yarrarapu S.N., Giri A.R., Kaur N., Moreno Franco P. Impact of colchicine on mortality and morbidity in COVID-19: a systematic review. Ann Med. 2022 Dec 31;54(1):775–789. - PMC - PubMed
    1. Lien C.H., Lee M.D., Weng S.L., Lin C.H., Liu L.Y., Tai Y.L., Lei W.T., Liu J.M., Huang Y.N., Chi H., Chiu N.C. Repurposing colchicine in treating patients with COVID-19: a systematic review and meta-analysis. Life. 2021 Aug 23;11(8):864. - PMC - PubMed